Theranostics Challenges
Are You Ready for the Growth of Theranostics?
Theranostics is rapidly evolving, offering new promise for personalized care. But without access to the right tools, this potential may remain unrealized.
Growing Patient Volumes & Workflow Complexities
Staffing shortages, burnout, and limited budgets make it difficult to take on increasing caseloads while achieving consistently high standards of quality.The Promise of Personalized Care Remains Unrealized
Without access to the right tools at the right time, valuable information in patients' PET/CT and SPECT/CT exams stays hidden and underutilized.A Rapidly Evolving Treatment Paradigm
The scientific and clinical communities are making quick progress producing new evidence around Theranostics. But health systems face the challenge of translating this evidence into their clinical practice.Enable Personalized Care Pathways
Wherever you are in your Theranostics journey, MIM gives you practical tools to unlock actionable insights from your patients' images. Precise quantitative insights provide confidence at every step of the patient's journey from therapy selection to therapy monitoring.
Improve Efficiency and Maintain Quality
MIM's automated and intuitive Theranostics solutions seamlessly integrate into your imaging workflow, helping you handle growing patient volumes and complexity while maintaining high-quality care.Deliver Personalized Care with Confidence
To inform personalized patient management decisions, MIM helps you unlock new biomarkers, such as SUVmean, discordance, total tumor volume, and absorbed dose.Stay Future-Ready
As Theranostics rapidly evolves, your ability to evolve is critical. Leverage MIM's flexibility to keep up and turn emerging best practices into clinical reality.Visualize the Entire Theranostics Pathway
Implement Personalized Care on a Single, Comprehensive Software Platform
PSMA
FDG
Patient Selection
Confidently Assess Patient Eligibility with LesionID® Pro
- Boost confidence with quantitative imaging biomarkers
- Measure total tumor burden (TTB) and whole-body SUVmean
- Auto-segment organs at risk for automated normal physiological uptake removal
- Visualize discordance to identify FDG-positive, PSMA-negative lesions
Therapy Response
Evaluate Patient Response to Therapy with LesionID Pro
- Trend tumor response longitudinally
- Quantify TTB changes based on PET/CTs and SPECT/CTs
- Track lesion activity and volume changes
- Quickly and accurately generate quantitative statistics for therapy response
Dosimetry
Calculate Absorbed Dose with
MIM SurePlan™ MRT
- Streamline and standardize workflows with automated reconstruction, segmentation, and dose calculation
- Utilize single-time-point and multi-time-point dosimetry
- Quantify absorbed dose with precision
Communicating Outcomes
Auto-Generate Reports
- Effectively communicate with patients and referring physicians
- Auto-generate DVH and relevant screens
- Tailor structured reports to your audience
- Easily review tumor progression and track dose across therapy cycles
MIM Theranostics Solutions
Simplify—and Future-Proof—Your Theranostics Pathway
- LesionID® Pro
- MIM SurePlan™ MRT
- MIM Encore®
- GE HealthCare
Help Improve Patient Care without Adding Time
Aid decision-making without increasing your workload. LesionID Pro gives clinicians time-saving tools to extract quantitative patient-specific insights from PSMA PET/CT and SPECT/CT studies, aiding in assessing tumor burden during planning and evaluation of treatment options, such as radiopharmaceutical therapy (RPT).
Dosimetry Made Easy
Centers performing radiopharmaceutical therapies need practical solutions to save time and maintain a high level of patient care. As therapy volumes continue to rise, how will you handle the demand?
Automate Nuclear Medicine with Flexible Standardization
Nuclear Medicine departments need practical solutions to save time and maintain a high level of patient care. As therapy volumes continue to rise, how will you handle the demand? Consider how standardizing your diagnostic workflow will enable you to balance efficiency and care.
Molecular Imaging and Theranostics
Cancer is personal. Its treatment should be too. GE HealthCare’s complete portfolio of Theranostics-enabling solutions is designed specifically for this new era in cancer care. Join us on this journey to transform the approach to cancer discovery, diagnosis, and treatment. Because the future of medicine is here—and it’s personal. Are you ready?
Resources
Overcome Barriers to Adopting Dosimetry in Theranostics
Insights
How Can You Realize the Promise of Theranostics?
Overcome Theranostics access barriers. See how MIM Software empowers clinics with imaging and image processing tools for efficient, personalized care.
How Does Quantitative Data Help in Patient Selection for 177Lu-PSMA-617 Theranostics?
See research supporting use of total tumor burden (TTB) in patient selection for 177Lu-PSMA-617 Theranostics, and learn about accessing these metrics.
Practical Dosimetry in Theranostics: A Guide for Resource-Constrained Clinics
Find out why personalized dosimetry is essential for radiopharmaceutical therapies and learn how to implement it effectively, even with limited resources.
Leading Health Systems Choose MIM
Integrated delivery networks and hospitals of all sizes rely on MIM to standardize their daily workflows.
Majority
of SNMMI-Designated Comprehensive Centers of Excellence Choose MIM SurePlan MRT for Theranostics3,300+
Global Healthcare Organizations Trust MIM
More MIM
Explore Our Imaging Solutions
Radiology & Nuclear Medicine
Help drive data empowered decisions, clinical efficiency, and effective treatment with MIM Software’s comprehensive suite of Radiology and Nuclear Medicine applications.
mpMRI Visualization and Analysis for Prostate
Import, analyze, predict, and report easily with powerful workflow automation in MIM Symphony Dx™. 3,000 centers globally rely on MIM to reduce turnaround times and help physicians improve outcomes and referrals.
Radiation Oncology
MIM Software’s innovative, vendor-neutral solutions simplify increasingly complex plans to improve and ensure plan quality while reducing time to treatment.
